NEWS & MEDIA

September 1, 2013
News Thrombolytic Drug Epygen Labs

A World Class Thrombolytic Drug At An Affordable Cost For The Masses

According to the WHO, amongst all non-communicable diseases, cardiovascular disease (CVD) is the major cause of death in both developed and developing countries. In the year […]
February 1, 2013

Epygen Opens Biotechnology Incubation Facility In India And Breaks Ground For Therapeutic Protein Plant

Epygen is pleased to announce opening of a state of art, Biotech incubation facility at Navi Mumbai, India. This consists of a full- fledged Bioprocessing Pilot […]
April 1, 2012
Epygen Labs Bio World Congress 2012

Bio World Congress 2012

Epygen presented its technology on enzymatic kinetics at the World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Florida.
March 1, 2012
News And Media ACS Epygen Labs

Epygen Enzyme Technology At 2012 American Chemical Society Meet

Epygen presented its mathematical model, for kinetic predictability of biopolymer breaking enzyme (Paper No. 292) at the American Chemical Society, national meet, San Diego, Spring 2012. […]